These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8934029)

  • 1. Should all pregnant women be offered carrier testing for fragile X syndrome?
    Finucane B
    Clin Obstet Gynecol; 1996 Dec; 39(4):772-82. PubMed ID: 8934029
    [No Abstract]   [Full Text] [Related]  

  • 2. [Genetics of Fragile X syndrome and its prevention].
    Boué J; Simon-Bouy B
    J Gynecol Obstet Biol Reprod (Paris); 1997; 26(3):273-9. PubMed ID: 9265049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for the fragile X syndrome: the necessity of international guidelines for molecular genetics predictive testing in general.
    Fryns JP
    Genet Couns; 1995; 6(4):293-6. PubMed ID: 8775414
    [No Abstract]   [Full Text] [Related]  

  • 4. Population based prenatal screening for the fragile X syndrome.
    Palomaki GE
    J Med Screen; 1994 Jan; 1(1):65-72. PubMed ID: 8790488
    [No Abstract]   [Full Text] [Related]  

  • 5. Case finding for the fragile X syndrome and its consequences.
    Turner G; Robinson H; Wake S; Laing S; Partington M
    BMJ; 1997 Nov; 315(7117):1223-6. PubMed ID: 9393231
    [No Abstract]   [Full Text] [Related]  

  • 6. The fragile X syndrome: implications of molecular genetics for the clinical syndrome.
    Rousseau F
    Eur J Clin Invest; 1994 Jan; 24(1):1-10. PubMed ID: 8187801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA testing for fragile X syndrome in schools for learning difficulties.
    Slaney SF; Wilkie AO; Hirst MC; Charlton R; McKinley M; Pointon J; Christodoulou Z; Huson SM; Davies KE
    Arch Dis Child; 1995 Jan; 72(1):33-7. PubMed ID: 7717734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population screening for fragile-X syndrome.
    Bonthron D; Strain L
    Lancet; 1993 Mar; 341(8847):769-70. PubMed ID: 8095681
    [No Abstract]   [Full Text] [Related]  

  • 9. Prenatal carrier testing for fragile X: counseling issues and challenges.
    Musci TJ; Moyer K
    Obstet Gynecol Clin North Am; 2010 Mar; 37(1):61-70, Table of Contents. PubMed ID: 20494258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges in prenatal screening and counselling for fragile X syndrome.
    Mak AS; Leung KY
    Hong Kong Med J; 2017 Apr; 23(2):108-9. PubMed ID: 28387201
    [No Abstract]   [Full Text] [Related]  

  • 11. Attitudes toward prenatal screening and testing for Fragile X.
    Fanos JH; Spangner KA; Musci TJ
    Genet Med; 2006 Feb; 8(2):129-33. PubMed ID: 16481897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and instability of fragile X alleles: implications for offering fragile X prenatal diagnosis.
    Cronister A; Teicher J; Rohlfs EM; Donnenfeld A; Hallam S
    Obstet Gynecol; 2008 Mar; 111(3):596-601. PubMed ID: 18310361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of fragile X pre-mutation carriers in the Chinese obstetric population using a robust FMR1 polymerase chain reaction assay: implications for screening and prenatal diagnosis.
    Cheng YK; Lin CS; Kwok YK; Chan YM; Lau TK; Leung TY; Choy KW
    Hong Kong Med J; 2017 Apr; 23(2):110-6. PubMed ID: 28253484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for fragile X syndrome: a model for genetic disorders?
    Barnicoat A
    BMJ; 1997 Nov; 315(7117):1174-5. PubMed ID: 9393215
    [No Abstract]   [Full Text] [Related]  

  • 15. Who should be offered genetic screening?
    Super M
    Postgrad Med J; 1993 Sep; 69(815):669-71. PubMed ID: 8255830
    [No Abstract]   [Full Text] [Related]  

  • 16. Rapid fragile X carrier screening and prenatal diagnosis using a nonradioactive PCR test.
    Brown WT; Houck GE; Jeziorowska A; Levinson FN; Ding X; Dobkin C; Zhong N; Henderson J; Brooks SS; Jenkins EC
    JAMA; 1993 Oct; 270(13):1569-75. PubMed ID: 8371467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 15-year-long Southern blotting analysis of FMR1 to detect female carriers and for prenatal diagnosis of fragile X syndrome in Taiwan.
    Tzeng CC; Tsai LP; Chang YK; Hung YJ; Chang YY; Su YP; Jiang JJ; Liang HM
    Clin Genet; 2017 Aug; 92(2):217-220. PubMed ID: 28139839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dilemmas in counselling females with the fragile X syndrome.
    de Vries BB; van den Boer-van den Berg HM; Niermeijer MF; Tibben A
    J Med Genet; 1999 Feb; 36(2):167-70. PubMed ID: 10051021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic counseling for fragile x syndrome: updated recommendations of the national society of genetic counselors.
    McConkie-Rosell A; Finucane B; Cronister A; Abrams L; Bennett RL; Pettersen BJ
    J Genet Couns; 2005 Aug; 14(4):249-70. PubMed ID: 16047089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility and acceptance of screening for fragile X mutations in low-risk pregnancies.
    Ryynänen M; Heinonen S; Makkonen M; Kajanoja E; Mannermaa A; Pertti K
    Eur J Hum Genet; 1999; 7(2):212-6. PubMed ID: 10196705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.